On Tuesday, Shares of New Oriental Education & Technology Group Inc. (NYSE:EDU), gained 2.63% to $25.33.
New Oriental Education & Technology Group, declared a transition in the role of the Company’s Chief Financial Officer.
Mr. Stephen Zhihui Yang, the current Vice President of Finance, will be promoted to Chief Financial Officer of the Company, effective April 21, 2015. Mr. Louis T. Hsieh, the current Chief Financial Officer, will remain as the Company’s President, overseeing overall corporate strategy and business development, and will continue to serve as a member of the board of directors. The Company anticipates a smooth transition as Mr. Hsieh and Mr. Yang have worked together at the Company for more than nine years.
Mr. Yang has been with New Oriental since 2006 and has held multiple positions since he joined the Company, counting Vice President of Finance, Deputy Director of the President’s Office and Senior Financial Manager. Mr. Yang has 18 years of professional experience in accounting, financial administration and corporate financial advisory services in various sectors. Preceding to joining New Oriental, Mr. Yang served as the Financial Director of Beijing Hua De Xin Investment Co., Ltd. and was a Senior Auditor at PricewaterhouseCoopers. Mr. Yang received his bachelor degree in economics from Guanghua School of Administration of Peking University.
Separately, New Oriental also declared its results for the third quarter of fiscal year 2015.
New Oriental Education & Technology Group Inc. provides private educational services primarily in the People’s Republic of China. It offers test preparation courses to students taking language and entrance exams used by educational institutions in the United States, the People’s Republic of China, and Commonwealth countries; and after-school tutoring courses for middle school and high school students to assist students enhance scores on entrance exams for admission into high schools or higher education institutions.
Shares of Tractor Supply Company (NASDAQ:TSCO), gained 2.59% to $90.82, during its last trading session, hitting its highest level.
Tractor Supply Company, intends to release its first quarter 2015 results after the market closes on Wednesday, April 22, 2015. In conjunction with this release, the administration of Tractor Supply Company will host a conference call at 5:00 p.m. Eastern Time on Wednesday, April 22, 2015, which will be simultaneously webcast live over the Internet at TractorSupply.com.
Tractor Supply Company operates rural lifestyle retail stores in the United States. It offers a selection of merchandise, counting equine, livestock, pet, and small animal products necessary for their health, care, growth, and containment; hardware, truck, towing, and tool products; seasonal products, such as heating products, lawn and garden items, power equipment, gifts, and toys; work/recreational clothing and footwear; and maintenance products for agricultural and rural use.
At the end of Tuesday’s trade, Shares of Silver Standard Resources Inc. (NASDAQ:SSRI), gained 2.56% to $5.61.
Silver Standard Resources, declared the dates for the first quarter 2015 merged financial results news release and conference call. Investors, media and the public are invited to listen to the conference call.
News release containing first quarter 2015 merged financial results: Tuesday, May 12, 2015 , after markets close.
Conference call and webcast: Wednesday, May 13, 2015 , at 11:00 a.m. EDT .
Silver Standard Resources Inc. engages in the acquisition, exploration, development, and operation of precious metal mineral properties in the Americas. The company primarily explores for silver, gold, zinc, and lead deposits.
Finally, Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), ended its last trade with 2.54% gain, and closed at $9.27, hitting its highest level.
Ariad Pharmaceuticals, declared the results of a series of preclinical studies on its investigational tyrosine kinase inhibitor (TKI), brigatinib (AP26113) at the American Association for Cancer Research (AACR) Annual Meeting 2015. Brigatinib is in development for the treatment of patients with anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer (NSCLC), who are resistant to crizotinib.
These data were comprised of in two presentations: “Discovery of AP26113, a potent, orally active inhibitor of anaplastic lymphoma kinase and clinically relevant mutants” and “The potent ALK inhibitor AP26113 can overcome mechanisms of resistance to first and second-generation ALK TKIs in preclinical models.”
ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia in the United States, Europe, and other territories.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
